Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

NCT02672111 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: CAM2038 q1w or q4w exposure to SL BPN/NX
DRUG: CAM2038 q1w or q4w new to BPN treatment

Sponsor

Braeburn Pharmaceuticals